Rapid Non-Invasive Brain Stimulation for Hoarding Disorder
Launched by STANFORD UNIVERSITY · Nov 27, 2024
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new treatment method called rapid non-invasive brain stimulation to see if it can help people with hoarding disorder. Hoarding disorder is a condition where individuals have difficulty parting with possessions, leading to clutter that can interfere with their daily lives. The study aims to determine if this brain stimulation technique can reduce the symptoms of hoarding.
To participate in the trial, you need to be between 18 and 70 years old and have a primary diagnosis of hoarding disorder with noticeable symptoms. It's important that you can understand and agree to the study procedures. However, individuals with certain medical conditions, those who are pregnant or nursing, or those who have had previous brain treatments may not be eligible. If you join the study, you can expect to receive the brain stimulation treatment in a safe and controlled environment, with guidance from the research team. This trial is currently not recruiting participants, but it aims to provide new insights into treatments for hoarding disorder in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age 18-70 years
- • 2. Primary diagnosis of hoarding disorder
- • 3. Sufficient severity of hoarding symptoms
- • 4. Willing and able to understand and complete consent and study procedures
- Exclusion Criteria:
- • 1. Psychiatric or medical conditions or medications that make participation unsafe
- • 2. Pregnant or nursing females
- • 3. Previous exposure to TMS or ECT
- • 4. History of any implanted device or psychosurgery
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Trial Officials
Carolyn I Rodriguez, MD, PhD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported